Jinpai wants to fully enter the pharmaceutical industry

According to the meeting of the Technical Committee of the China Brewery Industry Liquor Branch (Expanded), the company’s sales this year are expected to exceed RMB 4.3 billion, which will focus on the diversified expansion of “health wine” and go all out to enter the pharmaceutical industry.

“Healthy drinks accounted for 95% of sales of Jinpai brand, and this year's liquor industry will exceed 200 million yuan.” Wu Shaoxun, chairman of Jinpai Brand Co., Ltd., introduced that in the future, diversified construction will be centered around the brand of health wine, focusing on health products, medicines, etc. Strength in the area.

It is understood that Jinpai joint venture this year, Kyushu TCM, invest 200 million yuan to build a base for the cultivation of Chinese herbal medicines, and investment in a pharmaceutical company in Huangshi, Jinpai company in Sichuan this year invested a Luzhou-flavor liquor factory, will be the card Liquor seasoning base for the liquor industry.

Wu Shaoxun is not optimistic about the status quo of the health wine market. Around 2000, the market shares of Zhonghe and Yedao Lutuo Liquor and Jinjiu were similar, but from the current point of view, the gap is increasing, and the input of various companies is also quite large. The average annual sales volume of the health wine market is 100%. About 100 million, there is still room for the development of the market.